Antifungal Resistance in Cryptococcal Infections
Pathogens · 2024
DOI: 10.3390/pathogens13020128 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Marcia S C Melhem und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Sciences, Secretary of Health, São Paulo 01246-002, SP, Brazil. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal, Cryptococcosis, Cryptococcus neoformans. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of Brazil, National Council for Scientific and Technological Development (CNPq), the Ministry of Science and Technology of Brazil, Ministry of Science, Technology, and Innovation (MCTI), Brazil.
Abstract (Originalsprache)
Antifungal therapy, especially with the azoles, could promote the incidence of less susceptible isolates of Cryptococcus neoformans and C. gattii species complexes (SC), mostly in developing countries. Given that these species affect mostly the immunocompromised host, the infections are severe and difficult to treat. This review encompasses the following topics: 1. infecting species and their virulence, 2. treatment, 3. antifungal susceptibility methods and available categorical endpoints, 4. genetic mechanisms of resistance, 5. clinical resistance, 6. fluconazole minimal inhibitory concentrations (MICs), clinical outcome, 7. environmental influences, and 8. the relevance of host factors, including pharmacokinetic/pharmacodynamic (PK/PD) parameters, in predicting the clinical outcome to therapy. As of now, epidemiologic cutoff endpoints (ECVs/ECOFFs) are the most reliable antifungal resistance detectors for these species, as only one clinical breakpoint (amphotericin B and C. neoformans VNI) is available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Sciences, Secretary of Health, São Paulo 01246-002, SP, Brazil.
- Graduate Program in Infectious and Parasitic Diseases, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.
- Graduate Program in Tropical Diseases, State University of São Paulo, Botucatu 18618-687, SP, Brazil.
- Pathology Division, Adolfo Lutz Institute, São Paulo 01246-002, SP, Brazil.
- Grupo Fleury Laboratories, São Paulo 04701-200, SP, Brazil.
- Central Public Health Laboratory-LACEN, Mycology Unit, Adolfo Lutz Institut, São Paulo 01246-002, SP, Brazil.
ORCID-Profile: Marcia S C Melhem, Diniz Pereira Leite Júnior, Wellington S Fava, Anamaria M M Paniago, James Venturini
Förderung
- Ministry of Science and Technology of Brazil
- National Council for Scientific and Technological Development (CNPq), the Ministry of Science and Technology of Brazil
- Ministry of Science, Technology, and Innovation (MCTI), Brazil
- São Paulo Research Foundation (FAPESP)
Zitieren
APA
Melhem, M. S. C., Leite Júnior, D. P., Takahashi, J. P. F., Macioni, M. B., Oliveira, L., de Araújo, L. S., Fava, W. S., Bonfietti, L. X., Paniago, A. M. M., Venturini, J., & Espinel-Ingroff, A. (2024). Antifungal Resistance in Cryptococcal Infections. Pathogens. https://doi.org/10.3390/pathogens13020128
Vancouver
Melhem MSC, Leite Júnior DP, Takahashi JPF, Macioni MB, Oliveira L, de Araújo LS, et al. Antifungal Resistance in Cryptococcal Infections. Pathogens. 2024. doi:10.3390/pathogens13020128
BibTeX
@article{Melhem2024,
author = {Melhem, Marcia S C and Leite Júnior, Diniz Pereira and Takahashi, Juliana P F and Macioni, Milena Bronze and Oliveira, Lidiane de and de Araújo, Lisandra Siufi and Fava, Wellington S and Bonfietti, Lucas X and Paniago, Anamaria M M and Venturini, James and Espinel-Ingroff, Ana},
title = {Antifungal Resistance in Cryptococcal Infections},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13020128}
}
EUVIMED